Unicorn Nest Logo

Sitra

sitra.fi
Type

Venture Capital, Private equity

Status

Active

Location

Helsinki, Finland

Total investments

15

Average round size

3M

Portfolio companies

13

Rounds per year

0.27

Lead investments

3

Follow on index

0.13

Exits

1

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyVenture CapitalFinancial ServicesMobileFitnessHealth CareHealth DiagnosticsMedical DeviceTherapeuticsmHealth

Investor highlights

Industry focus
Climate techEnergy

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments
15
Lead investments
3
Exits
1
Rounds per year
0.27
Follow on index
0.13
Investments by industry
  • Health Care (9)
  • Biotechnology (5)
  • Therapeutics (3)
  • Health Diagnostics (3)
  • Medical Device (2)
    • Show 24 more
Investments by region
  • Finland (14)
  • Netherlands (1)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
2M
Group Appearance index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ipsat Therapies 03 Apr 2005 Biotechnology, Health Diagnostics, Therapeutics Late Stage Venture 9M Finland, Uusimaa, Helsinki

Similar funds

By same location

Inventure Venture Capital
Tesi Venture Capital
OpenOcean Venture Capital
Icebreaker.vc Venture Capital

By same geo focus

Conor Venture Partners Venture Capital
Maki.vc Venture Capital
Superhero Capital Venture Capital

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.